RxDoctor Payments Data

Thanh Hang Nguyen, MD

Surgery · Tampa, FLNPI 1487727376

Payments from drug & device makers

$5,220in general payments, 2019–2025

Across 69 payments — averaging $75.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Solventum Corporation$1K
  • Smith+Nephew$774
  • Organogenesis Inc.$675
  • Sotera Wireless, Inc.$312
  • KCI USA, Inc.$174
  • plus $404 from 12 others

What the payments were for

  • Speaking & faculty fees$62312%
  • Travel & lodging$2,60050%
  • Food & beverage$1,99638%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical7$1,680
Solventum Corporation10$1,200
Smith+Nephew15$774
Organogenesis Inc.10$675
Sotera Wireless, Inc.1$312
KCI USA, Inc.9$174
Hydrofera LLC3$130
Integra Lifesciences Corporation3$57
Polarityte, Inc.2$42
ETS Wound Care LLC1$27
Acell, Inc.1$24
Paratek Pharmaceuticals, Inc.1$24
Hollister Incorporated1$20
Johnson & Johnson1$19
Melinta Therapeutics, LLC1$18
Next Science LLC1$17
Cashflow Solutions, LLC1$14
RGH Enterprises LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,220 in reported general payments places this provider in the 55th percentile of 1,569 surgery providers in Florida.

See all surgery providers in Florida

Medicare billing

Part B allowed, 2024
$270,263
Medicare patients
135
Services billed
1,242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.15$13,911

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$774$13,91115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,569 surgery providers in Florida.

Other surgery in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →